CLARIVATE PLC
For the period ended Mar 31, 2025. Filed Apr 29, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed Apr 29, 2025
CLVT$2.39+0.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
Condensed Consolidated Statements of Cash Flows (Unaudited)
| Three Months Ended March 31, | ||
|---|---|---|
| (In millions) | 2025 | 2024 |
| Cash Flows From Operating Activities | ||
| Net income (loss) | $(103.9) | $(75.0) |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||
| Depreciation and amortization | 185.4 | 179.4 |
| Share-based compensation | 10.7 | 14.9 |
| Amortization of debt issuance costs | 2.9 | 4.7 |
| Other operating activities | 21.6 | 10.1 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (33.6) | 74.8 |
| Prepaid expenses | (14.7) | (11.8) |
| Other assets | 1.9 | (3.0) |
| Accounts payable | (5.8) | (37.3) |
| Accrued expenses and other current liabilities | (3.9) | (10.0) |
| Deferred revenues | 111.3 | 31.0 |
| Operating leases, net | (1.5) | (1.8) |
| Other liabilities | 0.8 | 0.2 |
| Net cash provided by operating activities | 171.2 | 176.2 |
| Cash Flows From Investing Activities | ||
| Capital expenditures | (60.9) | (64.4) |
| Net cash provided by (used for) investing activities | (60.9) | (64.4) |
| Cash Flows From Financing Activities | ||
| Principal payments on term loans | — | (47.4) |
| Payment of debt issuance costs and discounts | — | (20.0) |
| Repurchases of ordinary shares | (50.0) | — |
| Cash dividends on preferred shares | — | (18.9) |
| Payments related to tax withholding for share-based compensation | (6.4) | (8.6) |
| Other financing activities | (0.2) | (0.3) |
| Net cash provided by (used for) financing activities | (56.6) | (95.2) |
| Effects of exchange rates | 5.1 | (6.3) |
| Net change in cash and cash equivalents, including restricted cash | 58.8 | 10.3 |
| Cash and cash equivalents, including restricted cash, beginning of period | 295.2 | 370.7 |
| Cash and cash equivalents, including restricted cash, end of period | $354.0 | $381.0 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.